短程磁共振成像方案在活检初治男性前列腺癌检测中具有高诊断性能:磁共振成像可及性的下一步
这项前瞻性多阅片者头对头研究纳入626例活检初治男性,比较单平面「快速」双参数MRI、三平面非增强双参数MRI与增强多参数MRI对高级别前列腺癌的诊断性能。三种方案敏感度均为95%,快速双参数MRI特异度65%低于双参数MRI和多参数MRI的69%,活检避免率47%对49%,快速双参数MRI和多参数MRI采集时间分别为8分钟和13分钟,短于多参数MRI的16分钟。
要点
- 三种MRI方案对高级别前列腺癌的敏感度均为95%(180/190)。
- 快速双参数MRI特异度65%,低于双参数MRI和多参数MRI的69%。
- 快速双参数MRI活检避免率47%,双参数MRI和多参数MRI为49%。
核心结论
- 短程MRI方案能以更低的直接成本提高前列腺MRI可及性,快速双参数MRI的代价是约2%更多的活检和约1%更多低级别前列腺癌的过度检测。
- 作者认为,要在非专家、低通量、低场强扫描仪中实施该技术,还需进一步开展前瞻性研究。
研究设计与样本
- 前瞻性、多阅片者、头对头研究,纳入626例活检初治男性,时间范围为2015年2月至2018年2月。
- 所有男性行活检前增强多参数MRI,活检前由两名盲法专家阅片者评估「快速」双参数MRI、双参数MRI和多参数MRI。
- 随后行系统经直肠超声引导活检,多参数MRI可疑(前列腺影像报告和数据系统3-5分病灶)者还行MR-in-bore活检。
- 以MR-in-bore活检联合系统活检结果作为参考标准。
- 高级别前列腺癌定义为分级≥2。
主要发现
- 所有方案对高级别前列腺癌的敏感度均为95%(180/190;95%CI:91-97%)。
- 「快速」双参数MRI特异度为65%(285/436;95%CI:61-70%),双参数MRI和多参数MRI特异度为69%(299/436;95%CI:64-73%)。
- 快速双参数MRI检出低级别前列腺癌增加0.96%(6/626)。
- 快速双参数MRI活检避免率为47%,双参数MRI和多参数MRI为49%。
- 快速双参数MRI和双参数MRI采集时间分别为8分钟和13分钟,多参数MRI为16分钟,直接成本更低。
关键数值与推荐
- 高级别前列腺癌敏感度:所有方案95%(180/190;95%CI:91-97%)。
- 特异度:「快速」双参数MRI 65%(285/436;95%CI:61-70%),双参数MRI和多参数MRI 69%(299/436;95%CI:64-73%)。
- 活检避免率:快速双参数MRI 47%,双参数MRI和多参数MRI 49%。
- 采集时间:快速双参数MRI 8分钟,双参数MRI 13分钟,多参数MRI 16分钟。
- 阅片者间一致率:快速双参数MRI 90%,双参数MRI 93%。
临床怎么用
- 在专家中心使用短程MRI方案不损害有害疾病的检出,可增加MRI通量并降低直接成本。
- 快速双参数MRI的代价是约2%更多的活检和约1%更多低级别前列腺癌的过度检测。
- 作者认为,在非专家、低通量、低场强扫描仪中实施该技术前,还需进一步开展前瞻性研究。
局限性
- 主要局限性是这些结果在经验较少的中心的可推广性。
- 作者指出,要在非专家、低通量、低场强扫描仪中实施该技术,还需进一步开展前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To make magnetic resonance imaging (MRI) more accessible to men at risk of high-grade prostate cancer (PCa), there is a need for quicker, simpler, and less costly MRI protocols. OBJECTIVE: To compare the diagnostic performance of monoplanar ("fast" biparametric MRI [bp-MRI]) and triplanar noncontrast bp-MRI with that of the current contrast-enhanced multiparametric MRI (mp-MRI) in the detection of high-grade PCa in biopsy-naïve men. DESIGN, SETTING, AND PARTICIPANTS: A prospective, multireader, head-to-head study included 626 biopsy-naïve men, between February 2015 and February 2018. INTERVENTION: Men underwent prebiopsy contrast-enhanced mp-MRI. Prior to biopsy, two blinded expert readers subsequently assessed "fast" bp-MRI, bp-MRI, and mp-MRI. Thereafter, systematic transrectal ultrasound-guided biopsies (SBs) were performed. Men with suspicious mp-MRI (Prostate Imaging Reporting and Data System 3-5 lesions) also underwent MR-in-bore biopsy (MRGB). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Primary outcome was the diagnostic performance of each protocol for the detection of high-grade PCa. Secondary outcomes included the difference in biopsy avoidance, detection of low-grade PCa, acquisition times, decision curve analyses, inter-reader agreement, and direct costs. Results from combined MRGB and SB were used as the reference standard. High-grade PCa was defined as grade ≥2. RESULTS AND LIMITATIONS: Sensitivity for high-grade PCa for all protocols was 95% (180/190; 95% confidence interval [CI]: 91-97%). Specificity was 65% (285/436; 95% CI: 61-70%) for "fast" bp-MRI and 69% (299/436; 95% CI: 64-73%) for bp-MRI and mp-MRI. With fast bp-MRI, 0.96% (6/626) more low-grade PCa was detected. Biopsy could be avoided in 47% for the fast bp-MRI and in 49% for the bp-MRI and mp-MRI protocols. Fast bp-MRI and bp-MRI can be performed in 8 and 13min, respectively, instead of 16min at lower direct costs. Inter-reader agreement was 90% for fast bp-MRI protocol and 93% for bp-MRI protocol. A main limitation is the generalizability of these results in less experienced centers. CONCLUSIONS: Short MRI protocols can improve prostate MRI accessibility at a lower direct cost. For fast bp-MRI, this is at the cost of ∼2% more biopsies and ∼1% more overdetection of low-grade PCa. In order to implement this technique in nonexpert, low-volume, lower-field-strength scanners, further prospective studies have to be performed. PATIENT SUMMARY: We compared the value of three different magnetic resonance imaging (MRI) protocols for the detection of prostate cancer in men with elevated prostate-specific antigen levels. Our results show that, when used in expert centers, shorter MRI protocols do not compromise the detection of harmful disease. This increases MRI capacity at lower direct costs.
引用
- van der Leest M, Israël B, Cornel EB, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol. 2019. PMID: 31167748. doi:10.1016/j.eururo.2019.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。